Mechanisms for the reduction of 24,25-dihydroxyvitamin D3 levels and bone mass in 24-hydroxylase transgenic rats.

Medicine & Life Sciences

• 24,25-Dihydroxyvitamin D 3 100%
• Transgenic Rats 82%
• Mixed Function Oxygenases 67%
• Low Density Lipoprotein Receptor-Related Protein-2 61%
• Albumins 51%
• Bone and Bones 35%
• Carrier Proteins 33%
• Vitamin D-Binding Protein 29%
• dihydroxy-vitamin D3 27%
• Calcifediol 26%
• Nephritis 23%
• Albuminuria 23%
• Hyperlipidemias 20%
• Renal Insufficiency 17%
• Urine 14%
• Phenotype 11%
• Enzymes 10%
• Kidney 10%
• Genes 8%
• Proteins 7%

Chemical Compounds

• Reduction 27%
• Vitamin D 25%
• Plasma Level 24%
• Protein 24%
• Plasma 24%
• Amount 8%